Company: ADPT
Filing Date: 2025-04-29
Form Type: DEF 14A
Source: 0001193125-25-103752
Chunk: 48

Company: Adaptive Biotechnologies Corp
Filing Date: 2025-04-29
Form: DEF 14A
Chunk 48
---
2029  |     |              |   — |     |            |   — |
|                                           |     | 2/13/2020  |           |     |       200,000 |      -3 |    |     |             — |   |     |    31.71 |      |     | 2/13/2030  |           |     |            — |     |     |          — |     |
|                                           |     | 3/4/2021   |           |     |       107,314 |      -4 |    |     |         7,155 |   |     |    43.68 |      |     | 3/4/2031   |           |     |       11,447 |  -5 |     |     68,625 |     |
|                                           |     | 3/4/2022   |           |     |       318,549 |     -11 |    |     |       144,795 |   |     |    12.14 |      |     | 3/4/2032   |           |     |       92,670 | -12 |     |    555,557 |     |
|                                           |     | 3/6/2023   |           |     |        87,302 |     -16 |    |     |       112,247 |   |     |     8.46 |      |     | 3/6/2033   |           |     |       99,735 | -13 |     |    597,911 |     |
|                                           |     | 3/4/2024   |           |     |             — |         |    |     |             — |   |     |        — |      |     | —          |           |     |      350,000 | -18 |     |  2,098,250 | -18 |

| (1) | Reflects intrinsic value based on the closing price ($6.00) of our common stock on December 31, 2024. |

38

| (2) | Each equity award is subject to the acceleration of vesting provisions as set forth in the section titled “Potential Benefits and Payments on Termination or Change in Control.” |

| (3) | The shares underlying this option are fully vested. |

| (4) | The shares underlying this